XELJANZ XR 11mg Price

Overview

Welcome to Dwaey, specifically on XELJANZ XR 11mg page.
This medicine contains an important and useful components, as it consists of
Tofacitinib (as citrate)is available in the market in concentration

Name

Ambroxol

Precaution

**Ambroxol** is a mucolytic agent primarily used to treat respiratory conditions such as **chronic obstructive pulmonary disease (COPD)**, **asthma**, and **acute bronchitis** by thinning and loosening mucus in the airways. However, there are several precautions to consider before using ambroxol: - **Pregnancy and Breastfeeding**: Ambroxol is classified as **Category C** during pregnancy. While limited data on its safety during pregnancy exist, it should only be used if the potential benefits outweigh the potential risks to the fetus. It is excreted into breast milk, so caution is advised when used by breastfeeding women, especially during the first trimester. - **Renal and Hepatic Impairment**: Caution is recommended in patients with **renal** or **hepatic impairments** as the drug may accumulate in the body. In these cases, dose adjustments may be required. - **Gastrointestinal Disorders**: Patients with gastrointestinal issues such as **gastric ulcers** should use ambroxol with caution as it may cause **gastrointestinal upset** in some individuals. - **Allergies**: It is important to check for **hypersensitivity** to ambroxol or any of its components. If any allergic reactions (such as **rash**, **urticaria**, or **angioedema**) occur, the drug should be discontinued. **Monitoring Parameters**: - **Respiratory Symptoms**: Regular monitoring of respiratory function is important, particularly in patients with **severe lung diseases**. - **Liver and Kidney Function**: In patients with pre-existing liver or kidney conditions, liver and kidney function should be monitored due to the risk of accumulation. - **Allergic Reactions**: Any signs of **hypersensitivity** reactions should be assessed immediately. - **Gastrointestinal Side Effects**: Monitor for any **stomach discomfort** or signs of gastrointestinal distress, especially in those with a history of **gastric ulcers**.

Indication

Ambroxol is primarily used as a **mucolytic agent** to help reduce the viscosity of mucus and make it easier to expel from the respiratory system. Its key indications include: - **Chronic Respiratory Conditions**: Such as **COPD** and **chronic bronchitis**, where it helps in loosening and thinning mucus. - **Acute Respiratory Conditions**: Such as **acute bronchitis**, **asthma**, and **upper respiratory tract infections**, where it provides symptomatic relief by making it easier to clear mucus from the airways. - **Cystic Fibrosis**: It is also used in patients with **cystic fibrosis**, where thick mucus can block airways and cause infections. - **Post-surgical Respiratory Care**: Ambroxol is sometimes used to assist in **post-operative recovery** to reduce mucus accumulation.

Contra indication

Ambroxol should be avoided in the following conditions: - **Hypersensitivity**: Any history of allergic reactions to ambroxol or other mucolytic agents contraindicates its use. - **Severe Hepatic Impairment**: In patients with **severe liver dysfunction**, ambroxol should be avoided, as it can lead to accumulation and increased risk of toxicity. - **Severe Renal Impairment**: Patients with **severe renal impairment** may experience drug accumulation, so caution is advised, and dose adjustment may be required. - **Gastric Ulcers**: People with active **gastric ulcers** should avoid ambroxol due to the potential for gastrointestinal irritation or distress.

Side Effect

While ambroxol is generally well tolerated, it may cause side effects in some individuals: - **Gastrointestinal**: **Nausea**, **vomiting**, **diarrhea**, and **stomach discomfort** are possible, particularly in sensitive individuals or those with a history of gastrointestinal problems. - **Allergic Reactions**: Rarely, ambroxol can cause **allergic reactions** such as **rash**, **urticaria**, **angioedema**, or **difficulty breathing**. Severe reactions should prompt immediate discontinuation of the drug. - **Respiratory**: Some patients may experience **mild irritation of the throat** or **dry mouth**. - **Central Nervous System**: Rarely, some individuals may experience **dizziness**, **headache**, or **tiredness**. - **Skin**: Very rarely, **skin rashes** or **itching** can occur, indicating a potential allergic response.

Pregnancy Category ID

0

Mode of Action

Ambroxol works by **increasing the production of respiratory tract fluid** and **thinning mucus**, making it easier for the body to expel the mucus from the lungs and airways. It has **mucolytic properties** that help break down the structure of mucus, thus reducing its viscosity and promoting expectoration. Ambroxol also has **anti-inflammatory** effects, which can help reduce inflammation in the respiratory tract, further facilitating improved breathing. Additionally, ambroxol has been shown to stimulate the **production of surfactant** in the lungs, which helps maintain lung function and prevent collapse of the alveoli (small air sacs) in conditions like **acute respiratory distress**.

Interaction

Ambroxol interacts with several other medications, especially those that affect **respiratory** and **gastrointestinal systems**: - **Antibiotics**: Ambroxol enhances the absorption and effectiveness of certain **antibiotics**, such as **amoxicillin**, **erythromycin**, and **doxycycline**, by facilitating their penetration into the mucus membranes. This combination can be beneficial in treating infections, but monitoring is necessary for dose adjustments. - **Cough Suppressants**: **Antitussives** or **cough suppressants** (such as **codeine**) should not be used in conjunction with ambroxol without medical supervision, as the reduced ability to cough up mucus could lead to respiratory complications. - **Other Mucolytics**: Combining ambroxol with other **mucolytic agents** should be done with caution, as it could lead to excessive mucus production or difficulty in clearing the airways.

Pregnancy Category Note

Information not available

Adult Dose

- **Mucolytic Treatment**: - The usual dose for **adults** is **30 mg** three times a day. - For chronic conditions, such as **chronic obstructive pulmonary disease (COPD)**, the dose may be adjusted according to the severity of symptoms, but typically **60 mg** once or twice daily. - **Acute Respiratory Conditions**: - A typical dose for acute conditions like **acute bronchitis** is **30 mg** three times a day. - **Cystic Fibrosis**: Higher doses may be required, and the treatment should be individualized under the guidance of a healthcare provider.

Child Dose

- **Children over 6 years**: The typical dose for children aged 6 to 12 years is **15 mg** two to three times a day. - **Children under 6 years**: Ambroxol use in children under 6 years should be done under strict medical supervision, and the dose may vary based on the child’s weight and the severity of the condition.

Renal Dose

- In patients with **renal impairment**, the dose should be adjusted to avoid accumulation. Caution is advised, particularly in those with **severe renal dysfunction**. The **dosage interval** may need to be extended, or the dose reduced based on renal function.

Administration

Information not available